Evidence map›Paper›PMID 29884818›Full record

ArticleExperimental & molecular medicine2018

The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes.

Yu-Chu Wang, Kung-Chao Chang, Bo-Wen Lin, Jenq-Chang Lee, Chien-Hsien Lai, Li-Jyuan Lin, Yun Yen, Chang-Shen Lin, Shiang-Jie Yang, Peng-Chan Lin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yu-Chu WangDepartment of Biotechnology and Bioindustry Sciences, National Cheng-Kung University, Tainan, 70101, Taiwan.
Kung-Chao ChangDepartment of Pathology, National Cheng Kung University Hospital, Tainan, 70403, Taiwan.
Bo-Wen LinDepartment of Surgery, National Cheng Kung University Hospital, Tainan, 70403, Taiwan.
Jenq-Chang LeeDepartment of Surgery, National Cheng Kung University Hospital, Tainan, 70403, Taiwan.
Chien-Hsien LaiDepartment of Biotechnology and Bioindustry Sciences, National Cheng-Kung University, Tainan, 70101, Taiwan.
Li-Jyuan LinInstitute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng-Kung University, Tainan, 70101, Taiwan.
Yun YenPh.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, 11031, Taiwan.
Chang-Shen LinGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Shiang-Jie YangInstitute of Basic Medical Sciences, National Cheng Kung University, Tainan, 70101, Taiwan.
Peng-Chan LinDepartment of Internal Medicine, College of Medicine, , National Cheng Kung University Hospital, Tainan, 70403, Taiwan.
Chung-Ta LeeDepartment of Pathology, National Cheng Kung University Hospital, Tainan, 70403, Taiwan.
Liang-Yi HungDepartment of Biotechnology and Bioindustry Sciences, National Cheng-Kung University, Tainan, 70101, Taiwan. lyhung@mail.ncku.edu.tw.
National Cheng Kung University Hospital · TWNational Cheng Kung University · TWTaipei Medical University · TWKaohsiung Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneous nuclear ribonucleoprotein (hnRNP) Q1, an RNA-binding protein, has been implicated in many post-transcriptional processes, including RNA metabolism and mRNA splicing and translation. However, the role of hnRNP Q1 in tumorigenesis remains unclear. We previously performed RNA immunoprecipitation (RIP)-seq analysis to identify hnRNP Q1-interacting mRNAs and found that hnRNP Q1 targets a group of genes that are involved in mitotic regulation, including Aurora-A. Here, we demonstrate that altering the hnRNP Q1 level influences the expression of the Aurora-A protein, but not its mRNA. Stimulation with epidermal growth factor (EGF) enhances both binding between hnRNP Q1 and Aurora-A mRNA as well as the efficacy of the hnRNP Q1-induced translation of Aurora-A mRNA. The EGF/hnRNP Q1-induced translation of Aurora-A mRNA is mediated by the mTOR and ERK pathways. In addition, we show that hnRNP Q1 up-regulates the translation of a group of spindle assembly checkpoint (SAC) genes. hnRNP Q1 overexpression is positively correlated with the levels of Aurora-A and the SAC genes in human colorectal cancer tissues. In summary, our data suggest that hnRNP Q1 plays an important role in regulating the expression of a group of cell cycle-related genes. Therefore, it may contribute to tumorigenesis by up-regulating the translation of these genes in colorectal cancer.

Indexed as

MAP Kinase Signaling SystemMitosisCell Transformation, NeoplasticColorectal NeoplasmsEpidermal Growth FactorHCT116 CellsHeterogeneous-Nuclear RibonucleoproteinsHumansNeoplasm ProteinsEpidermal Growth FactorHeterogeneous-Nuclear RibonucleoproteinsNeoplasm ProteinsSYNCRIP protein, human

Identifiers

PMID29884818
PMCPMC5994831
OpenAlexW2806087812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.